DK235089D0 - Anvendelse af aetiprotimodae til fremstilling af et laegemiddel imod virusinfektioner - Google Patents
Anvendelse af aetiprotimodae til fremstilling af et laegemiddel imod virusinfektionerInfo
- Publication number
- DK235089D0 DK235089D0 DK235089A DK235089A DK235089D0 DK 235089 D0 DK235089 D0 DK 235089D0 DK 235089 A DK235089 A DK 235089A DK 235089 A DK235089 A DK 235089A DK 235089 D0 DK235089 D0 DK 235089D0
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- aetiprotimodae
- application
- virus infections
- against virus
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- PZEUAMSVHLMPBZ-UHFFFAOYSA-N 4-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanyl]butanoic acid Chemical compound CC=1N=C(SCCCC(O)=O)SC=1CC(O)=O PZEUAMSVHLMPBZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 150000007979 thiazole derivatives Chemical class 0.000 abstract 1
- 229950004047 tiprotimod Drugs 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3816603A DE3816603A1 (de) | 1988-05-16 | 1988-05-16 | Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK235089D0 true DK235089D0 (da) | 1989-05-12 |
| DK235089A DK235089A (da) | 1989-11-17 |
Family
ID=6354444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK235089A DK235089A (da) | 1988-05-16 | 1989-05-12 | Anvendelse af aetiprotimodae til fremstilling af et laegemiddel imod virusinfektioner |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4963577A (da) |
| EP (1) | EP0342565B1 (da) |
| JP (1) | JPH0217123A (da) |
| KR (1) | KR900017587A (da) |
| AT (1) | ATE92760T1 (da) |
| AU (1) | AU621110B2 (da) |
| CA (1) | CA1328616C (da) |
| DE (2) | DE3816603A1 (da) |
| DK (1) | DK235089A (da) |
| ES (1) | ES2059615T3 (da) |
| PT (1) | PT90560B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE144142T1 (de) * | 1991-01-10 | 1996-11-15 | Transcend Therapeutics Inc | Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen |
| US5747459A (en) * | 1991-02-04 | 1998-05-05 | Nestec, Ltd. | Method for insuring adequate intracellular glutathione in tissue |
| US5430045A (en) * | 1992-04-23 | 1995-07-04 | Free Radical Sciences, Inc. | Method of reducing or preventing bone marrow hypoplasia |
| TW252112B (da) * | 1993-08-19 | 1995-07-21 | Pfizer | |
| US5447712A (en) * | 1993-12-09 | 1995-09-05 | Free Radical Sciences | Method of reducing cyclophosphamide induced hemorrhagic cystitis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7001928A (da) * | 1969-02-11 | 1970-08-13 | ||
| BE850148A (fr) * | 1977-01-06 | 1977-07-06 | American Cyanamid Co | Procede pour prevoir ou traiter les infections a rhinovirus |
| DE3508665A1 (de) * | 1985-03-12 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | Heterocyclische sulfide und ihre anwendung als immunmodulatoren |
-
1988
- 1988-05-16 DE DE3816603A patent/DE3816603A1/de not_active Withdrawn
-
1989
- 1989-05-12 US US07/350,957 patent/US4963577A/en not_active Expired - Fee Related
- 1989-05-12 DK DK235089A patent/DK235089A/da not_active Application Discontinuation
- 1989-05-13 DE DE8989108663T patent/DE58905219D1/de not_active Expired - Fee Related
- 1989-05-13 EP EP89108663A patent/EP0342565B1/de not_active Expired - Lifetime
- 1989-05-13 ES ES89108663T patent/ES2059615T3/es not_active Expired - Lifetime
- 1989-05-13 AT AT89108663T patent/ATE92760T1/de not_active IP Right Cessation
- 1989-05-15 PT PT90560A patent/PT90560B/pt not_active IP Right Cessation
- 1989-05-15 JP JP1118842A patent/JPH0217123A/ja active Pending
- 1989-05-15 CA CA000599732A patent/CA1328616C/en not_active Expired - Fee Related
- 1989-05-15 AU AU34749/89A patent/AU621110B2/en not_active Ceased
- 1989-05-16 KR KR1019890006509A patent/KR900017587A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU621110B2 (en) | 1992-03-05 |
| DK235089A (da) | 1989-11-17 |
| KR900017587A (ko) | 1990-12-19 |
| AU3474989A (en) | 1989-11-16 |
| DE3816603A1 (de) | 1989-11-30 |
| PT90560A (pt) | 1989-11-30 |
| EP0342565A2 (de) | 1989-11-23 |
| EP0342565A3 (de) | 1991-02-06 |
| ES2059615T3 (es) | 1994-11-16 |
| US4963577A (en) | 1990-10-16 |
| JPH0217123A (ja) | 1990-01-22 |
| CA1328616C (en) | 1994-04-19 |
| EP0342565B1 (de) | 1993-08-11 |
| DE58905219D1 (de) | 1993-09-16 |
| ATE92760T1 (de) | 1993-08-15 |
| PT90560B (pt) | 1994-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK195690A (da) | Anvendelse af coumarinderivater til fremstilling af et laegemiddel mod human immundefekt-virus | |
| NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
| DK184890A (da) | Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme | |
| DK285690D0 (da) | Farmaceutisk doseringsform til medicinsk behandling af fisk | |
| NO172575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater | |
| BR9201253A (pt) | Composto,processo para a sua preparacao,agente diagnostico ou terapeutico e aplicacao do mencionado composto | |
| NO173239C (no) | Analogifremgangsmaate til fremstilling av et terapeutisk aktivt etopodofyllotoksinglukosidacylderivat | |
| DK5489D0 (da) | Anvendelse af substituerede amidforbindelser til fremstilling af farmaceutiske praeparater til behandling af haematologiske sygdomme | |
| MX9202763A (es) | Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene. | |
| DK235089A (da) | Anvendelse af aetiprotimodae til fremstilling af et laegemiddel imod virusinfektioner | |
| NO172643C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater | |
| DK627289D0 (da) | Anvendelse af bicyclononanderivater | |
| NO171847C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater | |
| DK95489D0 (da) | Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel | |
| NO922358D0 (no) | Tert.-butylfenyl-1-amino-4-hydroksybutanderivater, fremgangsmaate ved deres fremstilling og farmasoeytiske preparaterinneholdende forbindelsene | |
| DK298389D0 (da) | Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament | |
| DE3751597D1 (de) | Verwendung von 15-Deoxyspergualin als Arzneimittel. | |
| DK591787D0 (da) | Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel | |
| DK0454429T3 (da) | Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme | |
| NO172115C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser | |
| BR9302809A (pt) | Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral | |
| DE69129126D1 (de) | Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol | |
| DK561787D0 (da) | Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel | |
| FR2578745B1 (fr) | Preparations pharmaceutiques fluidifiant le sang | |
| NO169589C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |